General Information
CMC Magnetics DM2 ALMET C112-CTD2
A Phase 2, Double-Blind, Randomized, Placebo-Controlled,12-Week Parallel Dose-Ranging Study of ALP001E in Subjects With Type 2 Diabetes Mellitus on a Stable Dose of Metformin.
| Protocol | C112-CTD2 |
|---|---|
| Identifier | |
| UID | 42e63beb-dc4a-4f73-a8fd-7c5f5d8fd976 |
| Status | Not Selected |
| Phase | 2a |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 0 |
| NCT Number | - |
| Created | 2024-04-25 13:25 |
| Last Updated | 2025-02-04 21:15 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | No | |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Ebuh, MD, Valentine | VEbuh | No |
| Recruiter | - | No | |
| Coordinator | Hernandez, Leslie | LHernandez | No |
| Regulatory | Romero, Araselly | ARomero | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | CMC Magnetics |
|---|---|
| Division | CMC Magnetics |
| Team | CMC Magnetics |
| Managing Site | Lonestar Clinical Research, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Medpace, Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Lightgray |
| Currency | - |
